You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Superficial esophageal cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Superficial Esophageal Cancer Trial in Okayama (CLS2702C/CLS2702D)

Recruiting
  • Superficial Esophageal Cancer
  • CLS2702C/CLS2702D
  • Okayama, Japan
    Okayama University Hospital
Jul 29, 2021

Esophageal Cancer Trial in Korea, Republic of (procedure, drug, radiation)

Recruiting
  • Esophageal Cancer
  • Esophagectomy
  • +3 more
  • Goyang-si, Korea, Republic of
  • +8 more
Jan 16, 2023

Esophageal Tumors, Endoscopic Mucosal Resection, Hyaluronic Acid Trial in São Paulo (Submucous Endoscopic Dissection with

Recruiting
  • Esophageal Neoplasms
  • +2 more
  • Submucous Endoscopic Dissection with hydroxyethylamide
  • Submucous Endoscopic Dissection with Hyaluronic acid (TS-905 Blue Eye)
  • São Paulo, Brazil
    Instituto do Câncer do Estado de São Paulo
Oct 16, 2023

Esophageal Cancer Trial in Rochester (VLE imaging for staging EAC)

Completed
  • Esophageal Cancer
  • VLE imaging for staging EAC
  • Rochester, Minnesota
    Mayo Clinic
Sep 17, 2021

Full-field Coherence Tomography for ex Vivo Staging and

Recruiting
  • Esophagus Cancer
  • Non interventional study
  • Nantes, France
    Nantes University Hospital
Jun 22, 2021

Superficial Esophageal Cancers Trial in Nantes

Recruiting
  • Superficial Esophageal Cancers
    • Nantes, France
      CHU Nantes
    Jan 18, 2022

    Adjuvant Radiotherapy for pT1b Esophageal Cancer After

    Completed
    • Esophageal Cancer
      • Beijing, China
        National Cancer Center/Cancer Hospital, Chinese Academy of Medic
      Aug 10, 2022

      Endoscopic Submucosal Dissection Versus Esophagectomy for Early

      Completed
      • Esophageal Cancer
      • Endoscopic submucosal dissection
      • Esophagectomy
      • Shanghai, China
        Changhai Hospital, Naval Medical University
      Sep 27, 2023

      Esophagus Cancer Trial in Guangzhou (Cadonilimab, Paclitaxel and cisplatin, intensity-modulated radiotherapy)

      Not yet recruiting
      • Esophagus Cancer
      • Guangzhou, Guangdong, China
        Sun Yat-sen University
      Nov 20, 2023

      Esophageal Cancer, Esophageal Tumors Trial in Boston (Prehabilitation Program)

      Not yet recruiting
      • Esophageal Cancer
      • Esophageal Neoplasms
      • Prehabilitation Program
      • Boston, Massachusetts
        Massachusetts General Hospital
      Sep 6, 2023

      Esophageal Carcinoma Trial in Nanjing (Nimotuzumab, Tigio, Concurrent radiation therapy)

      Enrolling by invitation
      • Esophageal Carcinoma
      • Nanjing, Jiangsu, China
        The First Affiliated Hospital of Nanjing Medical University
      Sep 19, 2023

      Prevent Anastomotic Leakage After Esophagectomy Due to

      Not yet recruiting
      • Esophageal Cancer
      • +2 more
      • Eso-SPONGE®
      • Barcelona, Catalunya, Spain
        Hospital Clinic de Barcelona
      Oct 20, 2023

      Esophageal Tumor Metastatic, Esophageal Cancer Stage IVb Trial in Beijing (drug, biological, radiation)

      Recruiting
      • Esophageal Neoplasm Metastatic
      • Esophageal Cancer Stage IVb
      • TP (Paclitaxel with cisplatin or carboplatin) or PF (Fluoropyrimidine with cisplatin or carboplatin) regimen depended on investigator's choice.
      • +3 more
      • Beijing, Beijing, China
        Cancer hospital, CAMS
      Oct 19, 2023

      Esophageal Cancer Trial in Ramat Gan (CPAP)

      Recruiting
      • Esophageal Cancer
      • CPAP
      • Ramat Gan, Israel
        Sheba Medical Center
      Sep 13, 2023

      Symptoms Based on Patient-reported Outcomes in Immunotherapy for

      Not yet recruiting
      • Esophageal Cancer
      • +2 more
        • Guangzhou, Guangdong, China
          Guangdong Provincial People's Hospital
        Aug 24, 2023

        Patients in Esophageal Cancer Clinical Research

        Not yet recruiting
        • Esophageal Cancer
          • (no location specified)
          Apr 14, 2023

          Microbiome of Esophageal Cancer Patients and Post Esophagectomy

          Recruiting
          • Esophageal Tumors
            • Haifa, Israel
              Rambam Health Care Campus
            Nov 13, 2023

            Retrospective Review of Esophageal Cancer at MSKCC

            Recruiting
            • Esophageal Cancer
            • Esophagus Cancer
            • Esophagectomy
            • New York, New York
              Memorial Sloan Kettering Cancer Center (All Protocol Activities)
            Jan 23, 2023

            Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

            Recruiting
            • Metastatic Esophageal Squamous Cell Carcinoma
            • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
            • Qingdao, Shandong, China
            • +1 more
            Nov 13, 2023

            Follow-up Strategy for Esophageal Cancer Patients

            Active, not recruiting
            • Esophagus Cancer
            • follow-up with different time intervals
            • Guangzhou, Guangdong, China
              Jianhua Fu
            Sep 13, 2023

            Esophageal Tumors, Dysphagia Trial in São Paulo (Fully Covered Esophageal Prosthesis (FC-SEMS), Partially Covered Esophageal

            Recruiting
            • Esophageal Neoplasms
            • Dysphagia
            • Fully Covered Esophageal Prosthesis (FC-SEMS)
            • Partially Covered Esophageal Prosthesis (PC-SEMS)
            • São Paulo, Brazil
              Instituto do Câncer do Estado de São Paulo
            Oct 4, 2023

            Esophageal Carcinoma Trial in Shijiazhuang (toripalimab)

            Recruiting
            • Esophageal Carcinoma
            • Shijiazhuang, Hebei, China
              Fourth Hospital of Hebei Medical University
            Aug 20, 2023

            Esophageal Cancer Trial in Tianjin (Arm A, Arm B)

            Not yet recruiting
            • Esophageal Cancer
            • Arm A
            • Arm B
            • Tianjin, Tianjin, China
              Tianjin Cancer Hospital
            Sep 24, 2023

            Swedish Esophageal and Cardia Cancer Study

            Active, not recruiting
            • Oesophageal Cancer
            • +3 more
              • (no location specified)
              Sep 3, 2023

              Immunotherapy;Envafolimab; Esophageal Cancer Trial (Envafolimab, Abraxane, Cisplatin)

              Not yet recruiting
              • Immunotherapy;Envafolimab; Esophageal Cancer
              • (no location specified)
              Apr 24, 2023